For readers following ASX today live coverage, ResMed remains a key name within the ASX 200 today. Revenue growth was respectable, but earnings power explains why the update landed well. Adjusted gross margin improved, a change the company credited to productivity…
Acadia Q3 2026 earnings: raised DAYBUE guidance, solid NUPLAZID sales, and ADP pipeline updates. Earnings Call Insights: Acadia Pharmaceuticals (ACAD) Q3 2026 - "Quarter 3 was another strong quarter for Acadia" (CEO & Director Catherine Owen Adams). "In the third quarter, we delivered total revenues of $342 million…
DRI Healthcare Trust Q3 results show stronger earnings, rising cash receipts, and 84% EBITDA margin. - Diluted earnings per unit of $0.84, compared with a loss of $1.05 Y/Y - Normalized total cash receipts of $47.5M, up 9% Y/Y - Adjusted EBITDA of $40.0M, up 9% Y/Y, with…
Stock Price, News, Quote & History Yahoo! Finance Canada Oops, something went wrong Canada markets open in 7h 21m This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular…
In a report released yesterday, Luca Issi from RBC Capital maintained a Hold rating on Crispr Therapeutics AG, with a price target of $50.00. According to TipRanks, Issi is an analyst with an average return of -5.6% and a 36.64% success rate. Issi…
Under the proposed terms, the SPAC would acquire 100% of SkinJec in exchange for newly issued common stock of the combined company. Medicus said it seeks to retain majority economic and voting ownership of the separately listed entity, preserving shareholder participation…
The decision affects the planned US Phase 2 trial of BMB-101 in patients with DEEs Emcure Pharmaceuticals posts 24% revenue growth in Q2 FY27; profit jumps 29% Fresenius strikes landmark WuXi Biologics deal to nearly triple biosimilar pipeline to 66 molecules FDA places Bright Minds Biosciences…
Pakka Limited (Pakka) reduced planned preferential-issue proceeds to Rs 114.62 crore from Rs 129.91 crore after convertible warrants were undersubscribed. By September 30, 2026, Pakka had received Rs 51.09 crore, comprising fully subscribed equity shares and the 25% upfront payment on subscribed warrants, with the amount…
Piper Sandler analyst Derek Podhaizer maintained a Hold rating on Tenaris SA today and set a price target of $60.00. According to TipRanks, Podhaizer is a 5-star analyst with an average return of 11.7% and a 55.56% success rate. Podhaizer covers the Energy…
Hospitals, clinics, payers, med‑tech, telehealth, and healthcare services delivery.
An article joins this feed when it matches these terms. Each one is also a search of its own.